Showing results (1971-1980 of 2,037) with videos related to

Sort By:
Pageof 204
Evidence-Based Complementary and Alternative Medicine : Ecam|July 11, 2013
A preclinical evaluation of antimycin a as a potential antilung cancer stem cell agentChi-Tai Yeh, Chun-Li Su, Chi-Ying F Huang, et al.
Scandinavian Journal of Rheumatology|November 20, 2009
An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han populationZ T Liao, Y F Pan, J L Huang, et al.
Human Genomics|March 12, 2015
Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencingSuqin Liu, Hongjiang Wang, Lizhi Zhang, et al.
Journal of Visualized Experiments : Jove|March 20, 2018
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid LeukemiaJacqueline Cloos, Jeffrey R Harris, Jeroen J W M Janssen, et al.
Annals of Vascular Surgery|December 29, 2020
Higher Risk for Reintervention in Patients after Stenting for Radiation-Induced Internal Carotid Artery Stenosis: A Single-Center Analysis and Systematic ReviewYoung Erben, Camila Franco-Mesa, David Miller, et al.
Cancer Informatics|August 6, 2015
Identification of Genetic Mutations in Human Lung Cancer by Targeted SequencingHongxiang Feng, Xiaowei Wang, Zhenrong Zhang, et al.
Zhonghua Shao Shang Za Zhi = Zhonghua Shaoshang Zazhi = Chinese Journal of Burns|December 27, 2018
[Thoughts and principles of diagnosis and treatment of chronic refractory wounds in China]W Dong, Y R Xiao, M J Wu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2023
[A single-center study on the distribution and antibiotic resistance of pathogens causing bloodstream infection in patients with hematological malignancies]L J Cai, X L Wei, Y Q Wei, et al.
Oncotarget|June 20, 2015
Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinomaMing-Huang Chen, Chueh-Chuan Yen, Chi-Tung Cheng, et al.
Oncotarget|May 7, 2014
Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinomaMing-Huang Chen, Kun-Chun Chiang, Chi-Tung Cheng, et al.
Pageof 204